Review Article
Year : 2021 | Volume : 5 | Issue : 2 | Page : 45 - 48
Emergence, virology, immune response after SARS‐CoV‐2 infection, and role of immunopathology behind vaccination
R. Priyadharshini, M. P. Brundha, Sinduja Palati
Department of Pathology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India
Address for correspondence:
Dr. R. Priyadharshini, Department of Pathology, Saveetha Dental College, Saveetha Institute of Medical and Technical
Sciences, Chennai, Tamil Nadu, India.
E‐mail: priyadharshinir.sdc@saveetha.com
Abstract
In mid-January 2020, the WHO received information from the International Commission of Health about an outbreak of disease in the capital of Hubei province, Wuhan, in Central China. There was no evidence of human transmission or infection among health-care workers at that stage. Initially, the cases identified visiting the Wuhan live and seafood market prompted a suspicion that might be the source of the pandemic. Stumbling of more than 200 vaccines started with preclinical progress, but only approximately 40 vaccines entered clinical trials where some were not approved for human trials. This review addresses the genome sequence, immunopathology induced by virus, and vaccine.
Keywords: Immune response, immunopathology, SARS-CoV-2, virology
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
How to cite this article:
Priyadharshini R, Brundha MP, Palati S. Emergence, virology, immune response after SARS-CoV-2 infection, and role of immunopathology behind vaccination. Int J Clinicopathol Correl 2021;5:45-8.
